India, Aug. 11 -- image credit- shutterstock

Accord Plasma B.V., a subsidiary of Ahmedabad-based Intas Pharmaceuticals, has announced the execution of an agreement to acquire 100% of Prothya Biosolutions Belgium BV and each of its subsidiaries, a leading plasma-derived medicinal products (PDMP) business based primarily inthe NetherlandsandBelgium.

Subject to the satisfaction of customary closing conditions, including regulatory clearances, the deal is anticipated to close shortly.

This proposed acquisition marks a significant step in Intas and Accord's long-standing ambition to establish a global presence in the PDMP market, expanding Intas's established leadership inIndiainto a truly international footprint.

Binish Chudgar, Chairman ...